Novartis Bioventures Ltd filings

This page lists the SEC filings reported by Novartis Bioventures Ltd.

SEC filings by Novartis Bioventures Ltd ()
TypeFiled
SC 13G/A2024-02-13EDGAR
SC 13G2023-03-13EDGAR
SC 13G/A2022-02-11EDGAR
SC 13G/A2022-02-11EDGAR
SC 13G/A2022-02-11EDGAR
SC 13G/A2022-02-11EDGAR
SC 13G/A2021-02-23EDGAR
SC 13G/A2021-02-01EDGAR
SC 13G/A2021-02-01EDGAR
SC 13G/A2021-02-01EDGAR
SC 13G2021-02-01EDGAR
SC 13G2021-01-29EDGAR
SC 13G/A2020-09-22EDGAR
42020-07-02EDGAR
32020-06-25EDGAR
42020-06-22EDGAR
32020-06-18EDGAR
42020-06-17EDGAR
42020-06-12EDGAR
42020-06-09EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.